{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:01:55Z","timestamp":1791810115779,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031011","name":"APC Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI152516"],"award-info":[{"award-number":["R01 AI152516"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajt.2024.03.033","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:04:33Z","timestamp":1711544673000},"page":"1369-1381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40"],"prefix":"10.1016","volume":"24","author":[{"given":"Danya","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6779-5710","authenticated-orcid":false,"given":"Hongmin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-4068","authenticated-orcid":false,"given":"Ivana R.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-4421","authenticated-orcid":false,"given":"Mandy L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajt.2024.03.033_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"issue":"6581","key":"10.1016\/j.ajt.2024.03.033_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.033_bib3","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1182\/blood.V99.12.4601","article-title":"Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ajt.2024.03.033_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment","volume":"6","author":"Wekerle","year":"2000","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib5","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/eji.200526190","article-title":"Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation","volume":"35","author":"Fehr","year":"2005","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2024.03.033_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/imt.15.1","article-title":"Novel insights into anti-CD40\/CD154 immunotherapy in transplant tolerance","volume":"7","author":"Pinelli","year":"2015","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.033_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.174.1.542","article-title":"Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival","volume":"174","author":"Adams","year":"2005","journal-title":"J\u00a0Immunol."},{"issue":"5","key":"10.1016\/j.ajt.2024.03.033_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1600-6143.2011.03509.x","article-title":"CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates","volume":"11","author":"Thompson","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-6143.2011.03736.x","article-title":"Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates","volume":"12","author":"Badell","year":"2012","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2024.03.033_bib11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1600-6143.2012.04029.x","article-title":"CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8","volume":"12","author":"Badell","year":"2012","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2024.03.033_bib12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1600-6143.2012.04054.x","article-title":"A\u00a0novel monoclonal antibody to CD40 prolongs islet allograft survival","volume":"12","author":"Lowe","year":"2012","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2024.03.033_bib13","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/ajt.15835","article-title":"CD11b is a novel alternate receptor for CD154 during alloimmunity","volume":"20","author":"Liu","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2024.03.033_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861471","article-title":"The inhibition of CD40\/CD154 costimulatory signaling in the prevention of renal transplant rejection in nonhuman primates: a systematic review and meta analysis","volume":"13","author":"Perrin","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41467-018-02896-8","article-title":"A\u00a0ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense","volume":"9","author":"Wolf","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajt.2024.03.033_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fcvm.2017.00040","article-title":"CD40L and its receptors in atherothrombosis-an update","volume":"4","author":"Michel","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.111.247684","article-title":"Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice","volume":"109","author":"Wolf","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.ajt.2024.03.033_bib18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3389\/fimmu.2017.01791","article-title":"The CD40-CD40L dyad in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"8","author":"Aarts","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2024.03.033_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ni1333","article-title":"Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts","volume":"7","author":"Ochando","year":"2006","journal-title":"Nat Immunol"},{"issue":"51","key":"10.1016\/j.ajt.2024.03.033_bib20","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.1073\/pnas.1105500108","article-title":"Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40\/CD154 blockade","volume":"108","author":"Ferrer","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.033_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4049\/jimmunol.175.2.771","article-title":"Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation","volume":"175","author":"Quezada","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib22","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1600-6143.2004.00523.x","article-title":"CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates","volume":"4","author":"Kawai","year":"2004","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib23","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1600-6135.2003.00246.x","article-title":"Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection","volume":"3","author":"Ehst","year":"2003","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.033_bib24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":"Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection","volume":"104","author":"Trambley","year":"1999","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib25","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.4049\/jimmunol.172.9.5456","article-title":"In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy","volume":"172","author":"Chen","year":"2004","journal-title":"J\u00a0Immunol."},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib26","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.4049\/jimmunol.180.9.6077","article-title":"Long-term control of alloreactive B cell responses by the suppression of T cell help","volume":"180","author":"Li","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib27","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.4049\/jimmunol.1201757","article-title":"CD40\/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules","volume":"189","author":"Ferrer","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib28","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/ajt.12417","article-title":"An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig","volume":"13","author":"Pinelli","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2024.03.033_bib29","first-page":"1625","article-title":"Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation. J Immunol","volume":"183","author":"Gilson","year":"2009"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"10.1016\/j.ajt.2024.03.033_bib31","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.1202027","article-title":"Regulatory T cell induction, migration, and function in transplantation","volume":"189","author":"Burrell","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2024.03.033_bib32","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/ajt.15835","article-title":"CD11b is a novel alternate receptor for CD154 during alloimmunity","volume":"20","author":"Liu","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.033_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/TP.0b013e31815e883e","article-title":"A\u00a0new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection","volume":"85","author":"Brennan","year":"2008","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.033_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2024.03.033_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH13-08-0653","article-title":"Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice","volume":"112","author":"Willecke","year":"2014","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.ajt.2024.03.033_bib36","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.4049\/jimmunol.1301378","article-title":"Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1beta by downregulating their suppressor functions","volume":"191","author":"Raffin","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2024.03.033_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ajt.12678","article-title":"Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects","volume":"14","author":"Okimura","year":"2014","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2024.03.033_bib38","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1600-6143.2012.04014.x","article-title":"Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates","volume":"12","author":"Oura","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2024.03.033_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/TP.0000000000000236","article-title":"Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys","volume":"98","author":"Song","year":"2014","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2024.03.033_bib40","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.12330","article-title":"ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates","volume":"13","author":"Watanabe","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2024.03.033_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdd.2130","article-title":"Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis","volume":"39","author":"Anil Kumar","year":"2018","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.ajt.2024.03.033_bib42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/ajt.12082","article-title":"A\u00a0phase 1, randomized ascending single-dose study of antagonist anti-human CD40 ASKP1240 in healthy subjects","volume":"13","author":"Goldwater","year":"2013","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib43","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/TP.0000000000001344","article-title":"Costimulation blockade in kidney transplantation: an update","volume":"100","author":"Malvezzi","year":"2016","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2024.03.033_bib44","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/ajt.13377","article-title":"A\u00a0novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion","volume":"15","author":"Cordoba","year":"2015","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2024.03.033_bib45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/ajt.14872","article-title":"Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody","volume":"18","author":"Ristov","year":"2018","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib46","first-page":"192","article-title":"Nonclinical safety assessment of CFZ533, a Fc-Silent anti-CD40 antibody, in Cynomolgus monkeys","volume":"166","author":"Ulrich","year":"2018","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41598-017-00508-x","article-title":"IL-1beta induced HIF-1alpha inhibits the differentiation of human FOXP3(+) T cells","volume":"7","author":"Feldhoff","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ajt.2024.03.033_bib48","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.1001536","article-title":"IL-1beta-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells","volume":"185","author":"Li","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajt.2024.03.033_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/srep14674","article-title":"IL-1\u03b2 promotes Th17 differentiation by inducing alternative splicing of FOXP3","volume":"5","author":"Mailer","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12265-020-09994-3","article-title":"The CD40-CD40L dyad as immunotherapeutic target in cardiovascular disease","volume":"14","author":"Bosmans","year":"2021","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"1","key":"10.1016\/j.ajt.2024.03.033_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-017-0175-y","article-title":"Microglia-derived IL-1\u03b2 promotes chemokine expression by Muller cells and RPE in focal retinal degeneration","volume":"12","author":"Natoli","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ajt.2024.03.033_bib52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","article-title":"IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases","volume":"10","author":"Wooff","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2024.03.033_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2018.02.014","article-title":"Distinct CD40L receptors mediate inflammasome activation and secretion of IL-1\u03b2 and MCP-1 in cultured human retinal pigment epithelial cells","volume":"170","author":"Bian","year":"2018","journal-title":"Exp Eye Res"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524002430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:11:56Z","timestamp":1754010716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613524002430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1600613524002430"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2024.03.033","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.04.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}